Sumera I. Ilyas
Mayo Clinic(US)Ratio(SE)SUNY Downstate Health Sciences University(US)WinnMed(US)Kings County Hospital Center(US)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)Individual Differences(US)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Peptidase Inhibition and Analysis, Cancer-related gene regulation, Gallbladder and Bile Duct Disorders, MicroRNA in disease regulation
Most-Cited Works
- → Cholangiocarcinoma 2020: the next horizon in mechanisms and management(2020)2,374 cited
- → Cholangiocarcinoma — evolving concepts and therapeutic strategies(2017)1,672 cited
- → Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma(2013)1,324 cited
- → Cholangiocarcinoma(2021)800 cited
- → Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma(2020)381 cited
- → AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma(2022)303 cited